Liver Metastasis Completed Phase 1 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0029622 (Liver Metastasis)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00833807Hepatic Arterial Infusion of Nab-Paclitaxel in Patients With Metastatic Melanoma in the LiverTreatment